Nuclear medicine innovations help (drive) healthcare (benefits) Marcus HackerThomas BeyerFred Verzijlbergen Editorial Open access 22 November 2014 Pages: 173 - 175
Favourable outcomes of 177Lu-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours Raghava KashyapMichael S. HofmanRodney J. Hicks Original Article 11 September 2014 Pages: 176 - 185
Human cytomegalovirus and Epstein-Barr virus infection impact on 18F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy Claudio V. SoleFelipe A. CalvoEnrique Ochoa Original Article 01 October 2014 Pages: 186 - 196
The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer Ali Afshar-OromiehEleni AvtziUwe Haberkorn Original Article Open access 20 November 2014 Pages: 197 - 209
[68Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice Thomas KrohnFrederik A. VerburgFlorian F. Behrendt Original Article 24 September 2014 Pages: 210 - 214
PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma Marion AlcantaraJehan DupuisLoïc Ysebaert Original Article 20 September 2014 Pages: 215 - 221
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis Gitta BleekerBerthe L. van Eck-SmitGodelieve A. Tytgat Original Article Open access 30 September 2014 Pages: 222 - 230
The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas Lutz KretschmerHans Peter BertschCarsten Oliver Sahlmann Original Article 15 October 2014 Pages: 231 - 240
Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysis Hyung-Jun ImKyoungjune PakDong Soo Lee Original Article 06 September 2014 Pages: 241 - 251
Targeted radionuclide therapy with RAFT-RGD radiolabelled with 90Y or 177Lu in a mouse model of αvβ3-expressing tumours A. Bozon-PetitprinS. BacotJ. P. Vuillez Original Article 28 August 2014 Pages: 252 - 263
Prospective comparison of whole-body 18F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis David FusterXavier TomásFrancesca Pons Original Article 04 September 2014 Pages: 264 - 271
The value of 18F-fluoride PET/CT in the assessment of screw loosening in patients after intervertebral fusion stabilization Tanja SeifenMargarida RodriguesChristian Pirich Original Article 16 September 2014 Pages: 272 - 277
[89Zr]Oxinate4 for long-term in vivo cell tracking by positron emission tomography Putthiporn CharoenphunLevente K. MeszarosPhilip J. Blower Original Article Open access 31 October 2014 Pages: 278 - 287
Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging Robert GoldsteinJane SosabowskiKerry Chester Original Article Open access 13 November 2014 Pages: 288 - 301
Dynamic SPECT: evolution of a widely available tool for the assessment of coronary flow reserve Simona Ben-HaimDenis Agostini Editorial 24 October 2014 Pages: 302 - 304
Prospective evaluation of a new protocol for the provisional use of perfusion imaging with exercise stress testing W. Lane DuvallJohn A. SavinoMilena J. Henzlova Original Article 04 November 2014 Pages: 305 - 316
Targeting post-infarct inflammation by PET imaging: comparison of 68Ga-citrate and 68Ga-DOTATATE with 18F-FDG in a mouse model James T. ThackerayJens P. BankstahlFrank M. Bengel Original Article 12 August 2014 Pages: 317 - 327
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 Ronald BoellaardRoberto Delgado-BoltonBernd J. Krause Guidelines Open access 02 December 2014 Pages: 328 - 354
Comments on Fuster et al.: Prospective comparison of whole-body 18F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis Michael Soussan Letter to the Editor 14 October 2014 Pages: 355 - 355
Prospective comparison of whole-body 18F-FDG PET/CT and MRI of the spine in the diagnosis of haematogenous spondylodiscitis: response to comments by Soussan David FusterXavier TomásAlex Soriano Letter to the Editor 15 October 2014 Pages: 356 - 357
Lonie R. Salkowski: RadCases breast imaging Vincenzo CuccurulloAntonio Santoriello Book Review 28 August 2014 Pages: 358 - 358
Pier Francesco Rambaldi: Whole-body FDG PET Imaging in Oncology—Clinical Reports Vania Mallardo Book Review 08 August 2014 Pages: 359 - 359
Erratum to: The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas Lutz KretschmerHans Peter BertschCarsten Oliver Sahlmann Erratum 10 December 2014 Pages: 360 - 361
68Ga-PSMA ligand PET versus 18F-NaF PET: evaluation of response to 223Ra therapy in a prostate cancer patient Christian UprimnyAlexander KroissIrene J. Virgolini Image of the Month 08 October 2014 Pages: 362 - 363
The great mimicker: an extensive bone sarcoidosis James Patrick ButeauEugenia Ducharne AsuajeKhun Visith Keu Image of the Month 14 October 2014 Pages: 364 - 365
